NYMXF Projected Dividend Yield
Ord/Nymox Pharmaceutical Corp ( OTCBB : NYMXF )Nymox Pharmaceutical Corporation is a Canada-based biopharmaceutical company. Co. is focused on developing its drug candidate, NYMOZARFEX, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. Co. also has a patent portfolio covering its marketed products, its investigational drug as well as other therapeutic and diagnostic indications. It also has the U.S. and global patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. Its products also include NicAlert and TobacAlert. NicAlert is a simple test to determine smoking status. 21 YEAR PERFORMANCE RESULTS |
NYMXF Dividend History Detail NYMXF Dividend News NYMXF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |